Focused parathyroidectomy guided by intra-operative parathormone monitoring does not miss multiglandular disease in patients with sporadic primary hyperparathyroidism: A 10-year outcome

Surgery

Volumn 146, Issue 6, 2009, Pages 1021-1027

  Lew, John I ^a   Irvin III, George L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCIUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PARATHYROID HORMONE; PARATHYROIDECTOMY; RECURRENCE; TIME FACTORS; YOUNG ADULT;

EID: 70649090168     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.09.006     Document Type: Article

References (25)

1. Sackett W.R., Barraclough B., Reeve T.S., et al. World trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 137 (2002) 1055-1059
2. Udelsman R. Six hundred fifty six consecutive explorations for primary hyperparathyroidism. Ann Surg 235 (2002) 665-672
3. Westerdahl J., Lindblom P., and Bergenfelz A. Measurement of intraoperative parathyroid hormone predicts long-term operative success. Arch Surg 137 (2002) 186-190
4. Irvin G.L., Carneiro D.M., and Solorzano C.C. Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg 239 (2004) 704-708
5. Grant C.S., Thompson G., Farley D., et al. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 140 (2005) 472-478
6. Chen H., Pruhs Z., Starling J.R., et al. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 138 (2005) 583-590
7. Molinari A.S., Irvin III G.L., Deriso G.T., et al. Incidence of multiglandular disease in primary hyperparathyroidism determined by parathyroid hormone secretion. Surgery 120 (1996) 934-937
8. Purcell G.P., Dirbas F.M., Jeffrey R.B., et al. Parathyroid localization with high-resolution ultrasound and technetium Tc 99 m sestamibi. Arch Surg 134 (1999) 824-830
9. Carneiro D.M., Solorzano C.C., Nader M.C., et al. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate?. Surgery 134 (2003) 973-981
10. Siperstein A., Berber E., Mackey R., et al. Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery 136 (2004) 872-880
11. Clerici T., Brandle M., Lange J., et al. Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease. World J Surg 28 (2004) 187-192
12. Haciyanli M., Lal G., Morita E., et al. Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. J Am Coll Surg 197 (2003) 739-746
13. Siperstein A., Berber E., Barbosa G.F., et al. Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg 248 (2008) 420-428
14. Lee N.C., and Norton J.A. Multiple gland disease in primary hyperparathyroidism: a function of operative approach?. Arch Surg 137 (2002) 896-900
15. Sidhu S., Neill A.K., and Russell C.F.J. Long-term outcome of unilateral parathyroid exploration for primary hyperparathyroidism due to presumed solitary adenoma. World J Surg 27 (2003) 339-342
16. Westerdahl J., and Bergenfelz A. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg 246 (2007) 976-981
17. Russell C.F.J., Dolan S.J., and Laird J.D. Randomized clinical trial comparing scan directed unilateral versus bilateral cervical exploration for primary hyperparathyroidism due to solitary adenoma. Br J Surg 93 (2006) 418-421
18. Mun H.C., Conigrave A., Wilkinson M., et al. Surgery for hyperparathyroidism: does morphology or function matter most?. Surgery 138 (2005) 1111-1120
19. Elliott D.D., Monroe D.P., and Perrier N.D. Parathyroid histopathology: is it of any value today?. J Am Coll Surg 203 (2006) 758-765
20. Carneiro-Pla D.M., Romaguera R., Nadji M., et al. Does histopathology predict parathyroid hypersecretion and influence correctly the extent of parathyroidectomy in patients with sporadic primary hyperparathyroidism?. Surgery 142 (2007) 930-935
21. Consensus Development Conference Panel. Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus Development Conference statement. Ann Intern Med 114 (1991) 593-597
22. Irvin G.L., and Carneiro D.M. Management changes in primary hyperparathyroidism. JAMA 284 (2000) 934-936
23. Irvin G.L., Prudhomme D.L., Deriso G.T., et al. A new approach to parathyroidectomy. Ann Surg 219 (1994) 574-581
24. Irvin G.L., Sfakianakis G., Yeung L., et al. Ambulatory parathyroidectomy for primary hyperparathyroidism. Arch Surg 131 (1996) 1074-1078
25. Irvin G.L., Solorzano C.C., and Carneiro D.M. Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg 28 (2004) 1287-1292